JP2002537816A5 - - Google Patents

Download PDF

Info

Publication number
JP2002537816A5
JP2002537816A5 JP2000602796A JP2000602796A JP2002537816A5 JP 2002537816 A5 JP2002537816 A5 JP 2002537816A5 JP 2000602796 A JP2000602796 A JP 2000602796A JP 2000602796 A JP2000602796 A JP 2000602796A JP 2002537816 A5 JP2002537816 A5 JP 2002537816A5
Authority
JP
Japan
Prior art keywords
adenovirus
subgroup
recombinant
serotype
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000602796A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002537816A (ja
JP4683727B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2000/000133 external-priority patent/WO2000052186A1/en
Publication of JP2002537816A publication Critical patent/JP2002537816A/ja
Publication of JP2002537816A5 publication Critical patent/JP2002537816A5/ja
Application granted granted Critical
Publication of JP4683727B2 publication Critical patent/JP4683727B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000602796A 1999-03-04 2000-03-03 線維芽細胞様またはマクロファージ様細胞の形質導入のための手段と方法 Expired - Fee Related JP4683727B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99200624.7 1999-03-04
EP99200624 1999-03-04
PCT/NL2000/000133 WO2000052186A1 (en) 1999-03-04 2000-03-03 Means and methods for fibroblast-like or macrophage-like cell transduction

Publications (3)

Publication Number Publication Date
JP2002537816A JP2002537816A (ja) 2002-11-12
JP2002537816A5 true JP2002537816A5 (cg-RX-API-DMAC7.html) 2011-02-24
JP4683727B2 JP4683727B2 (ja) 2011-05-18

Family

ID=8239945

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000602796A Expired - Fee Related JP4683727B2 (ja) 1999-03-04 2000-03-03 線維芽細胞様またはマクロファージ様細胞の形質導入のための手段と方法

Country Status (7)

Country Link
EP (1) EP1159438B1 (cg-RX-API-DMAC7.html)
JP (1) JP4683727B2 (cg-RX-API-DMAC7.html)
AT (1) ATE403006T1 (cg-RX-API-DMAC7.html)
AU (1) AU776067B2 (cg-RX-API-DMAC7.html)
CA (1) CA2364499C (cg-RX-API-DMAC7.html)
DE (1) DE60039683D1 (cg-RX-API-DMAC7.html)
WO (1) WO2000052186A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US6929946B1 (en) 1998-11-20 2005-08-16 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
US6869936B1 (en) 1999-03-04 2005-03-22 Crucell Holland B.V. Means and methods for fibroblast-like or macrophage-like cell transduction
ATE519854T1 (de) * 1999-05-17 2011-08-15 Crucell Holland Bv Rekombinantes adenovirus auf basis von serotyp 48 (ad48).
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
WO2003104467A1 (en) 2002-04-25 2003-12-18 Crucell Holland B.V. Means and methods for the production of adenovirus vectors
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
EP1067188A1 (en) * 1999-07-08 2001-01-10 Introgene B.V. Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR)
DE60116513T2 (de) * 2000-08-10 2006-09-21 Crucell Holland B.V. Adenovirenvektoren zur transduktion der chondrozyten
EP1322774A2 (en) * 2000-09-20 2003-07-02 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for dendritic cells
DE60138403D1 (de) 2000-09-26 2009-05-28 Crucell Holland Bv Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten
AU2002211087A1 (en) * 2000-10-06 2002-04-15 Crucell Holland B.V. Gene delivery vectors for stem cells
EP1195440A1 (en) * 2000-10-06 2002-04-10 Introgene B.V. Gene delivery vectors for stem cells
US6905678B2 (en) * 2001-07-07 2005-06-14 Crucell Holland B.V. Gene delivery vectors with cell type specificity for mesenchymal stem cells
EP1279738A1 (en) * 2001-07-06 2003-01-29 Crucell Holland B.V. Gene delivery vectors with cell type specificity for mesenchymal stem cells
CA2478508C (en) 2002-04-25 2013-07-02 Crucell Holland B.V. Stable adenoviral vectors and methods for propagation thereof
EP1553983A2 (en) 2002-10-23 2005-07-20 Crucell Holland B.V. New settings for recombinant adenoviral-based vaccines
US20080153083A1 (en) 2003-10-23 2008-06-26 Crucell Holland B.V. Settings for recombinant adenoviral-based vaccines
EP1573012B1 (en) 2002-12-17 2011-11-30 Crucell Holland B.V. Recombinant viral-based malaria vaccines
SG11201507393TA (en) 2013-03-14 2015-10-29 Salk Inst For Biological Studi Oncolytic adenovirus compositions
ES2899913T3 (es) 2014-09-24 2022-03-15 Salk Inst For Biological Studi Virus tumorales oncolíticos y métodos de uso
EP3359175B1 (en) 2015-10-05 2020-09-16 Salk Institute for Biological Studies Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
EP3390645B1 (en) 2016-02-23 2022-09-14 Salk Institute for Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
WO2017147265A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
AU2017375633C1 (en) 2016-12-12 2023-04-27 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
WO2018125970A1 (en) * 2016-12-30 2018-07-05 Salk Institute For Biological Studies Synthetic adenoviruses targeting bone tissue and uses thereof
KR102702230B1 (ko) 2017-05-26 2024-09-03 에피센트알엑스, 인코포레이티드 트랜스진을 보유하는 재조합 아데노바이러스
BR112020019942A2 (pt) 2018-04-09 2021-01-26 Salk Institute For Biological Studies composições de adenovírus oncolítico com propriedades de replicação aprimoradas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723697B1 (fr) * 1994-08-17 1996-09-20 Rhone Poulenc Rorer Sa Methode de traitement de la restenose par la therapie genique
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
DE69633565T3 (de) * 1995-06-15 2013-01-17 Crucell Holland B.V. Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
CA2236912C (en) * 1995-11-28 2006-04-25 Genvec, Inc. Vectors and methods for gene transfer to cells
US20030017138A1 (en) * 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
EP1020529B1 (en) * 1998-11-20 2005-06-01 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
IL133032A (en) * 1998-11-20 2007-06-03 Introgene Bv Adenoviral gene delivery vectors provided with a tissue tropism for smooth muscle cells and /or endothelial cells

Similar Documents

Publication Publication Date Title
McCoy et al. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles
Kreppel et al. Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide
JP4733795B2 (ja) ヒツジアデノウイルスベクターを用いた遺伝子治療
CA2074502C (en) Vaccines
Tamanini et al. Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells
ATE403006T1 (de) Verwendung eines adenovirusvektors zur transduktion von synovialen zellen
DE59913833D1 (de) Strukturprotein von aav, seine herstellung und verwendung
Xu et al. Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences
CA2303477A1 (en) Chimaeric adenoviruses
JP2004501650A5 (cg-RX-API-DMAC7.html)
Ohga et al. Activin receptors are expressed on human lung fibroblast and activin A facilitates fibroblast-mediated collagen gel contraction
WO2001055362A3 (en) Hybrid adeno-retroviral vector for the transfection of cells
DE69739211D1 (de) Verpackungszellinien in der Verwendung zur Erleichterung der Entwicklung hocheffizienter adenoviraler Vektoren
Flood et al. Assembly of nucleocapsids with cytosolic and membrane-derived matrix proteins of vesicular stomatitis virus
WO2006033689A3 (en) Aav mediated gene delivery to cochlear cells
Mei et al. Two closely related adenovirus genome types with kidney or respiratory tract tropism differ in their binding to epithelial cells of various origins
JP2008508899A5 (cg-RX-API-DMAC7.html)
NO995697L (no) Gen-vektorer
Yao et al. Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver
Reddy et al. Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses
Fang et al. Differences in the post‐translational modifications of human papillomavirus type 6b major capsid protein expressed from a baculovirus system compared with a vaccinia virus system
MXPA01010849A (es) Utilizacion de adenovirus recombinante defectuoso que comprende un acido nucleico que codifica para un factor angiogenico para el tratamiento de la hipertension arterial pulmonar.
Mittal et al. Pathology and immunogenicity in the cotton rat (Sigmodon hispidus) model after infection with a bovine adenovirus type 3 recombinant virus expressing the firefly luciferase gene
WO2002024933A3 (en) Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells
WO2001092299A3 (en) Adenovirus particles with mutagenized fiber proteins